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Abstract
Whole grain intake is associated with lower CVD risk in epidemiological studies. It is unclear to what extent cereal fibre, located primarily
within the bran, is responsible. This review aimed to evaluate association between intake of whole grain, cereal fibre and bran and CVD risk.
Academic databases were searched for human studies published before March 2018. Observational studies reporting whole grain and cereal
fibre or bran intake in association with any CVD-related outcome were included. Studies were separated into those defining whole grain using
a recognised definition (containing the bran, germ and endosperm in their natural proportions) (three studies, seven publications) and those
using an alternative definition, such as including added bran as a whole grain source (eight additional studies, thirteen publications). Intake of
whole grain, cereal fibre and bran were similarly associated with lower risk of CVD-related outcomes. Within the initial analysis, where studies
used the recognised whole grain definition, results were less likely to show attenuation after adjustment for cereal fibre content. The fibre
component of grain foods appears to play an important role in protective effects of whole grains. Adjusting for fibre content, associations
remained, suggesting that additional components within the whole grain, and the bran component, may contribute to cardio-protective
association. The limited studies and considerable discrepancy in defining and calculating whole grain intake limit conclusions. Future research
should utilise a consistent definition and methodical approach of calculating whole grain intake to contribute to a greater body of consistent
evidence surrounding whole grains.
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CVD is a major cause of death worldwide, accounting for 31% of
deaths globally in 2015(1). As well as non-preventable risk factors
such as age and ethnicity, factors such as dyslipidaemia, hyper-
tension, abdominal obesity and pre-existing type 2 diabetes
mellitus (T2DM) can contribute to the risk of CVD(2,3). Diet can
play a role in managing and reducing the risk of these associated
factors, and a diet high in whole grains is consistently found to be
protective against CVD(4,5). ‘Whole grains’ refer to grains that
contain the relative proportions of bran, germ and endosperm as
they would occur naturally in the intact grain; as opposed to
refined grains that have the bran and germ removed during
processing. The precise mechanisms behind the cardio-protective
effects of whole grains are not yet completely understood; how-
ever, many of those proposed involve the role of the cereal fibre
located primarily within the bran component. For example, whole
grains high in soluble fibre, such as oats and barley, may reduce
the risk of CVD by decreasing serum LDL-cholesterol and
improving blood glucose and insulin responses(6).
While it is certain that the cereal fibre plays a role in the
cardio-protective association of whole grain foods, there is still
debate as to what extent it is responsible. There are other
constituents of the whole grain that may contribute to lower risk
of CVD, including Mg(7), vitamin E and bioactive compounds
such as phyto-oestrogens(8). It is commonly considered that the
contribution of these additional constituents, or perhaps, a
synergistic effect of consuming the grain’s nutrients and
bioactive compounds together, is greater than any benefits of
cereal fibre alone, if it were consumed outside of the
whole grain.
As the bran component of the grain, removed within the
refining process, contains the overwhelming majority of cereal
fibre as well as these other constituents within the aleurone
layer, comparing whole grain with refined grain intake is not
appropriate to address this question. Instead, research needs to
compare or adjust whole grain intake with cereal fibre intake
and bran specifically.
Abbreviations: CRP, C-reactive protein; HPFS, Health Professionals Follow-up Study; HR, hazard ratio; NHS, Nurses’ Health Study; RR, relative risk; T2DM, type
2 diabetes mellitus.
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However, a major issue in attempts to investigate compara-
tive association of cereal fibre, whole grain and bran to date, is
the lack of consistency in definition and calculation of whole
grains. Many of the large meta-analyses providing evidence for
the health association of whole grains draw conclusions based
on studies that define whole grains in various ways, including
those that consider added bran and germ as whole grain
sources(9,10). In addition, many studies determined whole grain
intake based on categorisation of mixed foods as either a whole
grain or a refined grain food rather than calculating whole grain
content as a dry weight of the ingredients within all foods. This
method has the potential to overestimate the contribution to
whole grain intake from some foods categorically considered
whole grain, for example, dark breads that may use some
refined flours. Alternative whole grain food definitions such as
breakfast cereals that contain at least 25% whole grain or
bran(11), or the recently developed 30% cut-off recommended
by the HEALTHGRAIN forum(12), have value in food labelling
but are problematic in defining precise levels of intake in
research. These methods can fail to capture the whole grain
consumed in small amounts from food which do not meet these
definitions but which could potentially accumulate to a sig-
nificant contribution to total intake.
Therefore, to investigate the true cardio-protective associa-
tion of whole grains, we considered the extent and quality of
evidence for whole grains analysed only when using a recog-
nised definition (namely, containing the bran, germ and endo-
sperm in their natural proportions) and calculated on a g/100 g
dry-weight basis. To provide insight into the comparative
association of the cereal fibre component outside of the whole
grain, we summarised evidence from studies that compared
CVD-related health associations of intake of whole grain with
intake of cereal fibre and/or bran.
Therefore, the aim of this review was to shed light on the
relative contribution of the cereal fibre and bran components to
the cardiovascular protective association found with whole
grain intake.
Methods
The systematic literature review was completed in accordance
with the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses guidelines(13). The details of the review were
recorded and registered with PROSPERO (International Pro-
spective Register of Systematic Reviews, http://www.crd.york.
ac.uk/PROSPERO), registration number CRD42017069226
before commencement.
Inclusion and exclusion criteria
Articles were required to have considered both whole grain
intake and cereal fibre and/or bran intake in association with
CVD-related health outcomes in humans. Since there were only
limited articles identified as meeting this criterion, no restric-
tions were placed on the CVD-related health outcomes exam-
ined and included. These could include but were not limited to
disease biomarkers, anthropometric measures, morbidity and
mortality. Results were restricted to those published in English
and contained within peer-reviewed journals, and there were
no restrictions based on the time of publication. Editorials,
reviews, meta-analyses and conference abstracts were
excluded.
Exposure – initial analysis. Articles must have reported on
total whole grain intake, and those examining intake of only a
defined set of whole grain foods or dietary patterns including
whole grains were excluded. The definition of whole grains
used was in accordance with that of American Association of
Cereal Chemists International (AACCI): ‘the intact, ground,
cracked or flaked caryopsis, whose principal anatomical com-
ponents – the starchy endosperm, germ and bran – are present
in the same relative proportions as they exist in the intact car-
yopsis’(14). This definition is similar to those used in Europe and
Australasia but critically defines whole grains, not whole grain
foods. Also, it means that articles that included added bran or
germ as a source of whole grain were excluded from the initial
analysis.
Exposure – expanded analysis. Initial scoping found a limited
amount of studies meeting the described inclusion criteria.
Consequently, a second review of the evidence was conducted,
expanding the criteria to include studies with a broader defi-
nition of whole grains. This expanded analysis includes studies
that may not have defined whole grains as per the AACCI
definition but may have utilised whole grain food definitions.
For example, several articles that utilised a categorisation sys-
tem of whole grain and refined grain foods, which categorised
added bran and germ as a whole grain food, were included in
an expanded analysis. Similarly, articles that met all other
selection criteria but did not clearly explain how whole grain
intake was defined or categorised were included in this
expanded analysis.
Comparison. To be considered for inclusion, studies must have
made a comparison of whole grain intake with cereal fibre and/
or bran intake. This may have been completed through
assessment of cereal fibre/bran intake separately, adjustment of
whole grain intake for cereal fibre/bran or by matching whole
grain and refined grain intake based on cereal fibre/bran con-
tent. Bran was included as an alternative comparison as it is the
portion of the grain containing the majority of the cereal fibre.
Study design. Due to wide disparity and potential differences
between acute exposure and long-term exposure, this paper
reports only the results of observational studies. Intervention
studies will be reported in a separate review. A summary of the
participants, exposure, comparisons, outcomes and study
design is presented in Table 1.
Search term and strategy
Relevant human journal articles were identified in medical
databases Scopus, Web of Science, CINAHL plus, CENTRAL in
Cochrane Library and PubMed published before March 2018
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using the following key words: ‘cardiovascular’, ‘coronary’,
‘stroke’, ‘cholesterol’, ‘triglycerides’, ‘lipids’, ‘obes*’, ‘over-
weight’, ‘glucose’ and ‘diabetes’ in combination with ‘whole-
grain*’ or ‘grain*’, as well as ‘cereal*’ or ‘bran’ and ‘fibre’ or
‘fiber’. The full search strategy (SCOPUS) has been presented in
online Supplementary material.
The titles of the articles were screened for inclusion by one
author. The abstracts of remaining articles were then reviewed.
After exclusion based on abstract, the full text of each poten-
tially eligible article was retrieved. Two authors (E. M. B. and
E. J. B.) separately assessed the full text studies for inclusion in
the review. The reference lists of included articles were hand
searched for additional studies that met the criteria.
Data extraction
One author (E. M. B.) extracted the required information and
summarised the data in table format, which was reviewed by a
second author (E. J. B.). Studies meeting the accepted defi-
nition of whole grains (initial analysis) were summarised
separately for expanded analysis. Within both groups, whole
grain, cereal fibre and bran intake data were extracted in
separate tables. Each summary table included first author’s last
name, publication year, study name, participants, country in
which the study was performed, CVD-related outcomes
examined, highest and lowest median intake, covariate
adjustments, main results and statistical significance. When
bran intake data were extracted, the table also included
whether the bran was total bran (naturally occurring plus
added) or added bran.
Quality assessment
The design of each included study was identified and recorded.
The National Health and Medical Research Council (NHMRC)
levels of evidence guidelines(15) were used to assign a level of
evidence to each study based on design. In addition, the
National Institutes of Health (NIH) Quality Assessment Tool for
Observational Cohort and Cross-Sectional Studies(16) was used
to guide critical appraisal of articles. The NIH quality assess-
ment tool provides a checklist of fourteen criteria that can be
applied to cohort and cross-sectional studies to evaluate inter-
nal validity. Studies were assessed on the basis of research
objective, study population specification, participation rate,
inclusion/exclusion criteria, sample size justification, time
frame, exposure and outcome measurement, blinding, attrition
and confounders. The NIH tool then includes a subjective
quality rating (good, fair or poor) that the reviewer decides on
based on their overall evaluation, rather than a direct numerical
ranking.
Method of analysis
Due to the wide range of CVD-related outcomes assessed
within limited studies, a meta-analysis was not possible. Instead,
studies were grouped based on comparison measure (cereal
fibre or bran intake) and where possible, on health outcome
assessed, and data were examined and synthesised qualita-
tively. The separation of articles within the initial and expanded
analysis allows an examination of how the quality of evidence
differs when restricted to articles using the currently accepted
definition of whole grains. The quality assessment process was
also used to inform the synthesis of results, with studies of
higher quality guiding the interpretation of findings and sub-
sequent discussion.
Results
Our search strategy identified 1909 articles (Fig. 1). Duplicates
were removed and titles were screened for relevance, with 671
articles selected for screening of abstract. After screening for
both title and abstracts, ninety-six full-text citations remained,
with a further seventy-three articles excluded because they did
not analyse both whole grain and cereal fibre or bran intake.
One article was excluded as it measured only non-CVD-related
outcomes, and two articles were excluded because they defined
cereal fibre as the fibre sourced from breakfast cereals only.
A further twelve articles were excluded from the initial analysis
because they did not use the AACCI definition of whole grain
and one article excluded based on no clear description of how
whole grain foods were defined (later included within the
expanded analysis). Seven articles (based on three studies)
remained in the initial analysis.
When the expanded criterion was applied to include the
articles that did not use the AACCI definition of whole grain,
thirteen previously excluded articles (eight additional studies)
were included (Fig. 1). They were previously excluded as ele-
ven of these articles included added bran and/or germ as a
source of whole grain, one article did not include whole grain
bread as a source of whole grain intake, and one article did not
provide sufficient detail as to how whole grain intake was
defined.
A summary of articles exploring the associations between
whole grain, cereal fibre and bran intake within the initial
analysis are presented in Tables 2, 3 and 4, respectively. Simi-
larly, Tables 5, 6 and 7 present a summary of articles in the same
format for when the criteria were expanded.
Table 1. PICOS criteria for inclusion and exclusion of studies in initial
analysis*
Parameter Description
Population Males and female humans of any age, health status,
socio-economic status and geographical location
Exposure Whole grain intake, whole grain defined according to
the AACCI definition†
Comparison Cereal fibre intake or bran intake
Outcomes Association of exposure/comparison on any
CVD-related health outcome
Study design Observational studies
PICOS, population, intervention, comparator, outcome, study design; AACCI,
American Association of Cereal Chemists International.
* PICOS criteria, population, intervention (exposure), comparator, outcomes, study
design.
† Expanded to include studies not meeting this definition in expanded analysis.
Whole grains and CVD 3
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Data extraction
Within the initial analysis, seven articles, which were based on
three primary studies, investigated various associations between
whole grain, bran and cereal fibre intake and cardiovascular-
related outcomes. The primary studies were the Nurses’ Health
Study (NHS) I and II and the Health Professionals Follow-up
Study (HPFS).
The following CVD-related outcomes were assessed in rela-
tion to whole grain and cereal fibre and/or bran intake within
the initial analysis, each within single article: incidence of
T2DM, CVD mortality and all-cause mortality in healthy parti-
cipants and those with diabetes, hypertension, CHD, long-term
weight gain and various inflammatory markers (Tables 2–4).
Within the expanded analysis (thirteen articles reporting on
eight new studies), two articles directly compared outcomes
between whole grain intake and bran intake and eight articles
directly compared outcomes between whole grain intake and
cereal fibre intake. One article adjusted whole grain intake for
cereal fibre intake, and one article compared association
between whole grain and non-whole grain intake matched on
cereal fibre content. The expanded analysis investigated the
incidence of T2DM (three articles), CVD mortality and all-cause
mortality in healthy participants (two articles), incidence of
CHD (one article), the metabolic syndrome (one article) and
stroke (one article): and markers of CVD risk, anthropometric
measures (three articles), blood lipid profile (two articles),
blood glucose measures (three articles), inflammatory markers
(one article) and change in coronary artery diameter and per-
centage stenosis (one article) (Tables 5–7).
Quality assessment
The level of evidence among the articles according to the
NHMRC guidelines ranged from level II (twelve prospective
cohort studies observing mortality or morbidity end points) to
level IV (six cross sectional analysis studies) (Table 8). Five of
the seven articles within the initial analysis were assigned a
level II, while seven of the thirteen articles within the expanded
analysis were assigned a level II.
While the majority of articles (10/19) were of good quality as
determined using the NIH quality assessment tool, the ratio of
good to fair quality was better in the initial analysis (6:1 v. 4:9 in
the expanded analysis) (Table 8). The study design used often
limited the quality that could be attained, with cross-sectional
design unable to measure exposure before outcome and unable
to assess associations over a sufficient time frame. In addition,
articles that only assessed exposure once over the study period
and articles that relied on self-reported outcome measures were
often assessed as lower quality than those that assessed expo-
sure multiple times and used validated measures.
Initial analysis
Of the seven articles that assessed whole grain intake in the
initial analysis, six found a significant inverse association with
CVD-related outcomes(5,17–21), however, two of these found the
association attenuated when adjusting for cereal fibre and
whole grain constituents(5,20). All six articles investigating bran
intake found a significant inverse association with CVD-related
outcomes(4,5,17–21), although one of these articles investigated
two separate cohorts and found a non-significant inverse
association in one cohort(19). There were mixed results on the
association with cereal fibre, with two articles showing a sig-
nificant inverse association(17,21) between intake and risk fac-
tors, and a third article showing no association(4).
Whole grain intake compared with bran intake. The highest
intake of whole grain was associated with 12% lower risk of
CVD mortality (hazard ratio (HR) 0·88, 95% CI 0·82, 0·96,
P= 0·001) and an 8% lower risk of all-cause mortality (HR 0·92,
95% CI 0·89, 0·96, P< 0·001) compared with the lowest intake
in a large combined cohort of the NHS I and the HPFS(18).
Within the same cohort, the association of high bran intake with
lower risk of CVD mortality was slightly greater. A 20% lower
risk for the highest intake of total bran (HR 0·80, 95% CI 0·73,
0·87, P< 0·001) and a 24% lower risk for the highest intake of
added bran (HR 0·76, 95% CI 0·70, 0·83, P< 0·001) compared
with lowest intake were observed. Similarly, high whole grain
and total bran intake were both associated with lower risk of
1909 articles found with
original search strategy
PubMed n 528
Scopus n 487
Web of Science n 598
CINAHL Plus n 157
CENTRAL in Cochrane Library
n 139
671 original research articles
for abstract screening
PubMed n 127
Scopus n 196
Web of Science n 177
CINAHL Plus n 116
Cochrane CENTRAL n 55
96 full-text articles were
reviewed against inclusion
criteria
7 articles (3 studies) remained
for inclusion in initial analysis
1238 articles removed
by title screening and
removing duplicates
575 non-relevant
articles removed after
abstract screening
89 full-text articles were excluded
• Did not report on both cereal fibre or
  bran and whole grain intake (n 73)
• Irrelevant study outcomes (n 1)
• Calculated cereal fibre as fibre from
  breakfast cereal only (n 2)
• Incorrect definition of whole grain
  used (n 12)
• Whole grain categorisation not
  defined (n 1)
13 articles (8 additional studies)
included in expanded analysis
Fig. 1. Flow diagram of study selection process.
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Table 2. Characteristics of studies within initial analysis exploring association of whole grain intake with outcomes related to CVD
Study first author, year
(reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
He, 2010(4) PCS NHS I 7822 F with
T2DM
USA CVD death 32·6 g/d 4·8 g/d Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate
RR 0·70 (95% CI
0·46, 1·06)
P= 0·07
All-cause death RR 0·89 (95% CI
0·69, 1·14)
P= 0·11
Jensen, 2004(5) PCS HPFS 42 850 M USA CHD 42·4 g/d 3·5 g/d Age, BMI, added bran intake, added
germ intake, energy intake,
smoking status, alcohol intake,
physical activity, family history of
MI, use of vitamin E supplement,
intake of PUFA, saturated fat,
trans fat, fruit, vegetables and fish
HR 0·84 (95% CI
0·71, 0·98)
P= 0·02
Whole grain constituent intake:
dietary fibre, folate, glycaemic
load, dietary vitamin B6, vitamin E,
Mg and Mn
HR 0·85 (95% CI
0·71, 1·02)
P= 0·06
Qi, 2006(17) Cross-
sectional
NHS I 902 F with
T2DM
USA CRP (mg/l) 35·4 g/d 4·75g/d Age, BMI, smoking status, alcohol
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg
Q1 6·60 v. Q5
5·52
P= 0·03
ICAM-1 (ng/ml) Q1 316 v. Q5 306 P= 0·19
E-selectin (ng/ml) Q1 65·6 v. Q5
65·4
P= 0·96
TNF-R2 (pg/ml) Q1 2647 v. Q5
2435
P= 0·017
Wu, 2015(18) PCS NHS I and
HPFS
74 341 F,
43 744 M
USA CVD death 47·8 g/d 4·2 g/d Age, ethnicity, BMI, smoking status,
pack years smoked, years since
quitting for past smoker, alcohol
intake, physical activity, family
history of diabetes, cancer and
heart disease, multivitamin use,
aspirin use at least once per
week, history of hypertension,
high cholesterol or diabetes at
baseline, total energy intake,
postmenopausal status and
postmenopausal hormone use,
modified alternative healthy eating
index (excludes whole grains)
HR 0·88 (95% CI
0·82, 0·96)*
P= 0·001
All-cause death HR 0·92 (95% CI
0·89, 0·96)*
P< 0·001
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Table 2. Continued
Study first author, year
(reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
De Munter, 2007(19) PCS NHS I 167 737 F USA T2DM 31·2 g/d 3·7 g/d Age, smoking status, physical
activity, alcohol intake, use of
hormone replacement therapy,
oral contraceptive use, family
history of T2DM, intake of coffee,
sugar-sweetened soft drinks and
fruit punch (non-alcoholic), total
energy intake, processed meat
intake, PUFA to saturated fat
intake ratio, BMI
RR 0·75 (95% CI
0·68, 0·83)
P< 0·001
NHS II 39·9 g/d 6·2 g/d RR 0·86 (95% CI
0·72, 1·02)
P= 0·03
Flint, 2009(20) PCS HPFS 31 684 M USA Hypertension 46·0 g/d 3·3 g/d Age, energy intake, family history of
CHD and hypertension, smoking
status, alcohol intake, marital
status, profession, height, fruit
and vegetable intake, Na intake,
physical activity, multivitamin use,
cholesterol screening
RR 0·81 (95% CI
0·75, 0·87)
P< 0·0001
Cereal fibre intake RR 0·94 (95% CI
0·84, 1·05)
P= 0·23
Koh-Banerjee, 2004(21) PCS HPFS 27 082 M USA Weight change over 8
years (kg)
23·8 g/d
change
–14·2 g/d
change
Age, baseline exposure, smoking
status, baseline weight, baseline
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake
Q1 1·24 (SD 0·23) v.
Q5 0·75 (SD 0·22)
P< 0·0001
PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; HPFS, Health Professionals Follow-up Study; M, male; HR, hazard ratio; CRP, C-reactive
protein; ICAM-1, intercellular adhesion molecule 1; TNF-R2, TNF receptor 2.
* Pooled HR for whole grain intake without added bran/germ. Located within Wu et al.(18) online Supplementary Table S4.
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Table 3. Characteristics of studies within initial analysis exploring associations of cereal fibre intake with outcomes related to CVD
Study first author,
year (reference) Study Cohort Participants Country Outcome Highest intake Lowest intake Covariates Results P
He, 2010(4) PCS NHS I 7822 F with T2DM USA CVD death 6·29 g/d 1·9 g/d Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate
RR 0·89 (95% CI
0·57, 1·41)
P=0·41
All-cause death RR 0·86 (95% CI
0·66, 1·12)
P=0·10
Qi, 2006(17) Cross-sectional NHS I 902 F with T2DM USA CRP (mg/l) N/A N/A Age, BMI, smoking status, alcohol
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg
N/A P=0·03
TNF-R2 (pg/ml) P=0·01
Koh-Banerjee,
2004(21)
PCS HPFS 27 082 M USA Weight change
over 8 years
(kg)
5·1 g/d change –2·2g/d change Age, baseline exposure, smoking
status, baseline weight, baseline
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake
Q1 1·10 (SD 0·20) v.
Q5 0·76 (SD 0·20)
P=0·0002
PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; CRP, C-reactive protein; N/A, not available; TNF-R2, TNF receptor 2; HPFS, Health
Professionals Follow-up Study; M, male.
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Table 4. Characteristics of studies within initial analysis exploring associations of bran intake with outcomes related to CVD
Study first author, year
(reference) Study Cohort Participants Country Outcome Bran
Highest
intake
Lowest
intake Covariates Results P
He, 2010(4) PCS NHS I 7822 F with
T2DM
USA CVD death Total* 9·7g/d 0·8 g/d Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate
RR 0·65 (95% CI
0·43, 0·99)
P= 0·04
Added† N/A 0·0 g/d RR 0·36 (95% CI
0·24, 0·54)
P< 0·001
All-cause death Total 9·7g/d 0·8 g/d RR 0·72 (95% CI
0·56, 0·92)
P= 0·01
Added N/A 0·0 g/d RR 0·45 (95% CI
0·36, 0·57)
P< 0·001
Jensen, 2004(5) PCS HPFS 42 850 M USA CHD Added 6·85g/d 0·0 g/d Age, BMI, added germ intake,
energy intake, smoking status,
alcohol intake, physical activity,
family history of MI, use of vitamin
E supplement, intake of PUFA,
saturated fat, trans fat, fruit,
vegetables and fish
HR 0·72 (95% CI
0·61, 0·84)
P< 0·001
Whole grain constituent intake:
dietary fibre, folate, glycaemic
load, dietary vitamin B6, vitamin E,
Mg and Mn
HR 0·71 (95% CI
0·59, 0·85)
P< 0·001
Qi, 2006(17) Cross-
sectional
NHS I 902 F with
T2DM
USA CRP (mg/l) Total 10·9 g/d 1·6 g/d Age, BMI, smoking status, alcohol
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg
Q1 6·29 v. Q5
4·96
P= 0·007
ICAM-1 (ng/ml) Q1 319 v. Q5 303 P= 0·11
E-selectin (ng/ml) Q1 67·2 v. Q5
68·1
P= 0·86
TNF-R2 (ng/ml) Q1 2603 v. Q5
2462
P= 0·06
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Table 4. Continued
Study first author, year
(reference) Study Cohort Participants Country Outcome Bran
Highest
intake
Lowest
intake Covariates Results P
Wu, 2015(18) PCS NHS I and
HPFS
74 341 F,
43 744 M
USA CVD death Total N/A N/A Age, ethnicity, BMI, smoking status,
pack years smoked, years since
quitting for past smoker, alcohol
intake, physical activity, family
history of diabetes, cancer and
heart disease, multivitamin use,
aspirin use at least once per week,
history of hypertension, high
cholesterol or diabetes at baseline,
total energy intake, postmenopausal
status and postmenopausal
hormone use (for women), modified
alternative healthy eating index
(excludes whole grains)
HR 0·80 (95% CI
0·73, 0·87)
P< 0·001
Added ≥6·0 g/d 0 g/d HR 0·76 (95% CI
0·70, 0·83)‡
P< 0·001
All-cause death Total N/A N/A HR 0·94 (95% CI
0·90, 0·99)§
P= 0·02
Added ≥6·0 g/d 0 g/d HR 0·93 (95% CI
0·89, 0·97)‡
P= 0·006
De Munter, 2007(19) PCS NHS I 167 737 F USA T2DM Total 9·6g/d 0·6 g/d Age, smoking status, physical activity,
alcohol intake, use of hormone
replacement therapy, oral
contraceptive use, family history of
T2DM, intake of coffee, sugar-
sweetened soft drinks and fruit
punch (non-alcoholic), total energy
intake, processed meat intake,
PUFA:saturated fat intake ratio, BMI
RR 0·72 (95% CI
0·65, 0·80)
P< 0·001
NHS II Total 12·0 g/d 1·1 g/d RR 0·84 (95% CI
0·71, 1·00)
P= 0·07
Flint, 2009(20) PCS HPFS 31 684 M USA Hypertension Total 12·0 g/d 0·3 g/d Age, energy intake, family history of
CHD and hypertension, smoking
status, alcohol intake, marital
status, profession, height, fruit
and vegetable intake, Na intake,
physical activity, multivitamin use,
cholesterol screening
RR 0·85 (95% CI
0·78, 0·92)
P= 0·002
Koh-Banerjee, 2004(21) PCS HPFS 27 082 M USA 8-year weight
change (kg)
Added 7·3g/d
change
0·0 g/d Age, baseline exposure, smoking
status, baseline weight, baseline
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake, baseline and changes in
natural bran
Q1 1·16 (SD 0·23) v.
Q3 1·00 (SD 0·20)
P= 0·01
PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; N/A, not available; HPFS, Health Professionals Follow-up Study; M, male; HR, hazard ratio;
CRP, C-reactive protein; ICAM-1, intercellular adhesion molecule 1; TNF-R2, TNF receptor 2.
* Bran consumed naturally within whole grains and bran added to food/consumed separately.
† Bran added to food/consumed separately only.
‡ Located within Wu et al.(18) online Supplementary Table S7.
§ Located within Wu et al.(18) online Supplementary Table S6.
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Table 5. Characteristics of studies within expanded analysis exploring associations of whole grain intake with outcomes related to CVD
Study first author,
year (reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
Jensen, 2006(22) Cross-sectional HPFS and NHS II 468 M+470 F USA Total cholesterol
(mmol/l)
43·8 g/d 8·2 g/d Age, sex, total energy intake,
alcohol intake, smoking
status, BMI, physical activity,
hypercholesterolaemia,
intake of fruit, vegetable,
saturated fat, MUFA and
PUFA
Q1 5·7 (SE 0·08) v.
Q5 5·6 (SE 0·07)
P= 0·02
HDL-cholesterol
(mmol/l)
Q1 1·7 (SE 0·03) v.
Q5 1·6 (SE 0·03)
P= 0·05
LDL-cholesterol
(mmol/l)
Q1 3·3 (SE 0·07) v.
Q5 3·2 (SE 0·06)
P= 0·10
HbA1c (%) Age, sex, total energy intake,
alcohol intake, smoking
status, BMI, physical activity,
hypercholesterolaemia,
intake of fruit, vegetable,
sucrose and fructose
Q1 5·50 (SE 0·04) v.
Q5 5·49 (SE 0·04)
P= 0·83
Insulin (pmol/l) Q1 91·7 (SE 4·9) v.
Q5 78·5 (SE 5·6)
P= 0·13
C-peptide (ng/ml) Q1 2·13 (SE 0·08) v.
Q5 1·84 (SE 0·08)
P= 0·03
Leptin (ng/ml) Q1 9·02 (SE 1·03) v.
Q5 8·03 (SE 1·04)
P= 0·03
CRP (mg/l) Q1 0·92 (SE 1·07) v.
Q5 0·88 (SE 1·07)
P= 0·63
Fibrinogen (g/l) Q1 2·2 (SE 0·03) v.
Q5 2·2 (SE 0·03)
P= 0·77
IL-6 (pg/ml) Q1 1·20 (SE 1·04) v.
Q5 1·13 (SE 1·05)
P= 0·87
Homocysteine
(µmol/l)
Q1 13·2 (SE 0·6) v.
Q5 10·9 (SE 0·3)
P< 0·001
Liu, 1999(23) PCS NHS I 75 521 F USA CHD 2·70
serves/d*
0·13
serves/d
Age, BMI, smoking status,
alcohol intake, family history
of MI before 60 years, self-
reported history of
hypertension or
hypercholesterolaemia,
menopausal status, protein
intake, aspirin use, use of
multiple vitamin or vitamin E
supplements, vigorous
activity, total energy intake
and saturated fat, MUFA,
PUFA and trans fat intake
RR 0·75 (95% CI
0·59, 0·95)
P= 0·01
Whole grain constituent intake:
dietary fibre, folate, vitamin
B6 and vitamin E
RR 0·79 (95% CI
0·62, 1·01)
P= 0·07
Juan, 2017(24) PCS NHS I and HPFS 71 750 F+42 823 M USA Stroke F: 33·23 g/d F: 4·43 g/d Age, BMI, smoking status,
alcohol intake, physical
activity, family history of
diabetes mellitus, cancer
and heart disease,
multivitamin use,
hypertension or high
cholesterol at baseline, total
energy intake, modified
alternative eating index
score (did not include whole
grains), menopausal status
and postmenopausal
hormone use
HR 1·03 (95% CI
0·88, 1·21)
P= 0·35
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Table 5. Continued
Study first author,
year (reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
M: 47·90 g/d M: 5·92 g/d HR 1·06 (95% CI
0·85, 1·32)
P= 0·37
N/A N/A Pooled HR 1·04
(95% CI 0·91,
1·19)
P= 0·97
Fung, 2002(25) PCS HPFS 42 898 M USA T2DM 3·2 serves/d 0·4 serves/d Age, time period, physical
activity, energy intake,
missing FFQ, smoking
status, family history of
diabetes, alcohol intake, fruit
intake, vegetable intake and
BMI
RR 0·70 (95% CI
0·57, 0·85)
P= 0·0006
Cereal fibre intake RR 0·98 (95% CI
0·76, 1·26)
P= 0·98
Montonen, 2003(26) PCS FMC 4316 F+M Finland T2DM 302 g/d 79 g/d Age, sex, geographic area,
energy intake, smoking
status, BMI and intake of
fruit, berries and vegetables
RR 0·65 (95% CI
0·36, 1·18)
P= 0·02
Cereal fibre intake RR 1·14 (95% CI
0·49, 2·66)
P= 0·63
Meyer, 2000(27) PCS IWHS 35 988
postmenopausal F
USA T2DM 20·5 serves/
week
1·0 serves/
week
Age, total energy intake, BMI,
waist:hip ratio, education,
smoking status, alcohol
intake and physical activity
RR 0·79 (95% CI
0·65, 0·96)
P= 0·0089
Cereal fibre intake RR 0·93 (95% CI
0·75, 1·16)
P= 0·46
McKeown, 2004(28) Cross-sectional FOS 2834 M+F USA Mean HOMA-IR 20·4 serves/
week
0·9 serves/
week
Age, sex, BMI, waist:hip ratio,
smoking status, total energy
intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for BP
Q1 6·8 (6·6, 7·1) v.
Q5 6·6 (6·4, 6·9)
P= 0·05
Cereal fibre intake Q1 6·8 v. Q5 6·7 P= 0·34
Metabolic
syndrome
Sex, age, smoking status, total
energy intake, alcohol
intake, percentage saturated
fat, percentage PUFA,
multivitamin use and
physical activity
OR 0·67 (95% CI
0·48, 0·91)
P= 0·01
Cereal fibre intake OR 0·77 (95% CI
0·55, 1·09)
P= 0·20
Huang, 2015(29) PCS NIH-AARP Diet
and Health
Study
367 442 M+F USA CVD death 1·20 oz/d 0·13 oz/d Age, sex, smoking status, race/
ethnicity group, alcohol
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
HR 0·83 (95% CI
0·78, 0·88)
P< 0·001
Cereal fibre intake HR 0·95 (95% CI
0·88, 1·03)
P= 0·19
All-cause death Age, sex, smoking status, race/
ethnicity group, alcohol
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
HR 0·83 (95% CI
0·81, 0·86)
P< 0·0001
Cereal fibre intake HR 0·94 (95% CI
0·90, 0·97)
P= 0·002
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Table 5. Continued
Study first author,
year (reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
Jacobs, 2000(30) PCS IWHS 11 040
postmenopausal F
USA CHD death 4·7 g whole
grain fibre/
8368 kJ
(2000
kcal)
1·3 g whole
grain fibre/
8368 kJ
(2000
kcal)
Age, energy intake,
educational status, marital
status, hypertension,
diabetes, heart disease,
cancer, BMI, waist:hip ratio,
age at first birth, physical
activity score, smoking
status, pack years of
cigarette smoking, alcohol
intake, vitamin supplement
use, hormone replacement
therapy use, percentage
energy from total fat,
saturated fat and
carbohydrates, intake per
4184kJ (1000kcal) of fibre
from non-grain sources, intake
of red meat, fish and seafood
HR 0·89 (95% CI
0·66, 1·20)
P> 0·05
Other CVD death HR 0·75 (95% CI
0·54, 1·06)
P> 0·05
All-cause death HR 0·83 (95% CI
0·73, 0·94)
P< 0·05
Erkkila, 2005(31) PCS ERA 229 postmenopausal F
with coronary
atherosclerosis
USA Change in min.
coronary artery
diameter (mm)
>6 serves/
week
≤6 serves/
week
Age, location of coronary
segment, BMI, smoking
status, use of cholesterol-
lowering medication and
hormone replacement
therapy, diabetes, education,
clinic, time of follow-up,
alcohol intake, coronary
artery bypass, percutaneous
transluminal coronary
angioplasty, energy intake,
saturated fat, PUFA and
cholesterol intake, serum
total, HDL- and LDL-
cholesterol, TAG and
systolic BP
Lowest intake:
–0·10 (SD 0·02) v.
highest intake:
–0·06 (SD 0·02)
P= 0·04
Change stenosis
(%)
Lowest intake: 3·62
(SD 0·86) v.
highest intake:
1·69 (SD 0·90)
P= 0·09
Newby, 2007(32) Cross-sectional BLSA 1516 F+M USA Diastolic BP
(mmHg)
45·4 g/d 0·62 g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, use
of BP medication and
hypertension
Q1 79·8 (SE 0·6) v.
Q5 79·2 (SE 0·7)
P= 0·42
Systolic BP
(mmHg)
Q1 129·2 (SE 1·0) v.
Q5 128·3 (SE 1·0)
P= 0·79
Total cholesterol
(mmol/l)
45·6 g/d 0·63 g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, use
of lipid-lowering medication
and hypercholesterolaemia
Q1 5·71 (SE 0·06) v.
Q5 5·49 (SE 0·06)
P= 0·02
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Table 5. Continued
Study first author,
year (reference) Study Cohort Participants Country Outcome
Highest
intake
Lowest
intake Covariates Results P
HDL-cholesterol
(mmol/l)
54·0 g/d 4·1 g/d Q1 1·27 (SE 0·02) v.
Q5 1·22 (SE 0·02)
P= 0·07
LDL-cholesterol
(mmol/l)
54·8 g/d 3·9 g/d Q1 3·16 (SE 0·06) v.
Q5 2·96 (SE 0·06)
P= 0·04
TAG (mmol/l) Q1 1·23 (SE 0·05) v.
Q5 1·16 (SE 0·05)
P= 0·22
Fasting glucose
(mmol/l)
45·4 g/d 0·56 g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, oral
hypoglycaemic medication
and diabetes
Q1 5·49 (SE 0·06) v.
Q5 5·49 (SE 0·06)
P= 0·57
2h glucose
(mmol/l)
50·6 g/d 1·1 g/d Q1 8·24 (SE 0·17) v.
Q5 7·32 (SE 0·17)
P= 0·006
Fasting insulin
(pmol/l)
51·5 g/d 2·2 g/d Q1 71·6 (SE 3·9) v.
Q5 71·8 (SE 4·1)
P= 0·90
2h insulin (pmol/l) 51·7 g/d 2·4 g/d Q1 479 (SE 38·0) v.
Q5 414 (SE 39·1)
P= 0·43
BMI (kg/m2) 46·0 g/d 0·65 g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains
Q1 25·5 (SE 0·2) v.
Q5 24·8 (SE 0·2)
P< 0·0001
Weight (kg) Q1 75·0 (SE 0·7) v.
Q5 72·6 (SE 0·2)
P= 0·004
Waist
circumference
(cm)
49·3 g/d 0·94 g/d Q1 87·4 (SE 0·6) v.
Q5 85·0 (SE 0·6)
P= 0·002
McKeown, 2009(33) Cross-sectional 3 year trial (vitamin
K and bone loss)
324 M+F USA BMI (kg/m2) 2·86
serves/d
0·21
serves/d
Age, sex, total energy intake,
percentage energy from fat,
physical activity, smoking
status, alcohol intake and
multivitamin use
Q1 26·8 (25·7,
28·1) v. Q4 25·8
(24·6, 27·1)
P= 0·08
Body fat (%) Q1 34·5 (32·7,
36·3) v. Q4 32·1
(30·1, 34·1)
P= 0·02
Trunk fat mass (%) Q1 43·0 (40·4,
45·5) v. Q4 39·4
(36·7, 42·1)
P= 0·02
Van de Vijver,
2007(34)
Cross-sectional NLCS 4237 M+F Netherlands BMI (kg/m2) N/A N/A Age, energy intake, intake of
animal protein, education,
smoking status, number of
cigarettes, intake of fruit and
vegetables
M: β –0·03 (–0·05,
–0·02)
P< 0·01
F: β –0·04 (–0·06,
–0·01)
P< 0·01
Overweight risk M: OR 0·98 (95%
CI 0·96, 0·99)
P< 0·01
F: OR 0·98 (95%
CI 0·96, 0·99)
P< 0·01
Obesity risk M: OR 0·90 (95%
CI 0·84, 0·98)
P< 0·05
F: OR 0·96 (95%
CI 0·93, 0·99)
P< 0·05
HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; CRP, C-reactive protein; PCS, prospective cohort study; MI, myocardial infarction; RR, relative risk; HR, hazard ratio; T2DM, type 2 diabetes
mellitus; FMC, Finnish Mobile Clinic Health Examination Survey; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMA-IR, homoeostatic model assessment of insulin resistance; ERA, Estrogen Replacement
and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort Study; N/A, not available.
* One whole grain serve (s): one slice bread; one cup breakfast cereal, rice, pasta, other grain, popcorn, cooked oatmeal; one tablespoon bran, wheat germ.
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Table 6. Characteristics of studies within expanded analysis exploring associations of cereal fibre intake with outcomes related to CVD
Study first author,
year (reference) Study Cohort Participants Cou-ntry Outcome Highest intake Lowest intake Covariates Results P
Montonen, 2003(26) PCS FMC 4316 F+M Finland T2DM 24·5–111 g/d 0·47–12·0 g/d Age, sex, geographic area,
energy intake, smoking
status, BMI and intake of
fruit, berries and vegetables
RR 0·39 (95% CI
0·20, 0·77)
P= 0·01
Meyer, 2000(27) PCS IWHS 35 988 F USA T2DM 9·43 g/d 2·66g/d Age, total energy intake, BMI,
waist:hip ratio, education,
smoking status, alcohol
intake and physical activity
RR 0·64 (95% CI
0·53, 0·79)
P= 0·0001
Whole grain intake RR 0·66 (95% CI
0·53, 0·83)
P= 0·0001
McKeown, 2004(28) Cross-sectional FOS 2834 M+F USA Mean HOMA-IR 8·0 g/d 2·6g/d Age, sex, BMI, waist:hip ratio,
smoking status, total energy
intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for
blood pressure
Q1 6·8 (6·5, 7·0) v.
Q5 6·6 (6·3, 6·8)
P= 0·02
Whole grain intake Q1 6·9 v. Q5 6·5 P= 0·003
Metabolic
syndrome
Sex, age, smoking status, total
energy intake, alcohol
intake, percentage saturated
fat, percentage PUFA,
multivitamin use and
physical activity
OR 0·62 (95% CI
0·45, 0·86)
P= 0·002
Huang, 2015(29) PCS NIH-AARP
Diet and
Health
Study
367 442 M+F USA CVD death 10·22 g/d 2·02g/d Age, sex, smoking status, race/
ethnicity group, alcohol
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
HR 0·80 (95% CI
0·75, 0·85)
P< 0·0001
All-cause death HR 0·81 (95% CI
0·79, 0·84)
P< 0·0001
Erkkila, 2005(31) PCS ERA 229 postmenopausal
F with coronary
atherosclerosis
USA Change in min.
coronary artery
diameter (mm)
>3g/4184 kJ
(1000 kcal)
≤3 g/4184 kJ
(1000 kcal)
Age, location of coronary
segment, BMI, smoking
status, use of cholesterol-
lowering medication and
hormone replacement
therapy, diabetes, education,
clinic, time of follow-up,
alcohol intake, coronary
artery bypass, percutaneous
transluminal coronary
angioplasty, energy intake,
saturated fat, PUFA and
cholesterol intake, serum
total, HDL-, and LDL-
cholesterol, TAG and
systolic blood pressure
Lowest: –0·09 v.
highest: –0·04
P= 0·03
Change stenosis
(%)
Lowest: 3·44 v.
highest: 1·79
P= 0·10
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Table 6. Continued
Study first author,
year (reference) Study Cohort Participants Cou-ntry Outcome Highest intake Lowest intake Covariates Results P
Newby, 2007(32) Cross-sectional BLSA 1516 F+M USA Diastolic BP
(mmHg)
9·43 g/d 2·19g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of blood
pressure-lowering
medication and
hypertension
Q1 79·5 (SE 0·8) v.
Q5 79·2 (SE 0·8)
P= 0·90
Systolic BP
(mmHg)
Q1 128·7 (SE 1·0) v.
Q5 129·7 (SE 1·0)
P= 0·27
Total cholesterol
(mmol/l)
9·56 g/d 2·2g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of lipid-
lowering medication and
hypercholesterolaemia
Q1 5·73 (SE 0·06) v.
Q5 5·44 (SE 0·06)
P= 0·005
HDL-cholesterol
(mmol/l)
11·49 g/d 2·9g/d Q1 1·23 (SE 0·02) v.
Q5 1·25 (SE 0·02)
P= 0·59
LDL-cholesterol
(mmol/l)
Q1 3·13 (SE 0·06) v.
Q5 2·99 (SE 0·06)
P= 0·07
TAG (mmol/l) 9·58 g/d 2·2g/d Q1 1·24 (SE 0·05) v.
Q5 1·15 (SE 0·05)
P= 0·12
Fasting glucose
(mmol/l)
9·67 g/d 2·27g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, oral
hypoglycaemic medication
and diabetes
Q1 5·55 (SE 0·05) v.
Q5 5·52 (SE 0·05)
P= 0·95
2 h glucose
(mmol/l)
10·42 g/d 2·39g/d Q1 8·05 (SE 0·21) v.
Q5 6·48 (SE 0·21)
P= 0·02
Fasting insulin
(pmol/l)
11·63 g/d 2·54g/d Q1 68·9 (SE 4·0) v.
Q5 73·0 (SE 4·0)
P= 0·68
2 h insulin (pmol/l) Q1 438 (SE 38·8) v.
Q5 413 (SE 38·2)
P= 0·33
BMI (kg/m2) 9·51 g/d 2·19g/d Age, age2, sex, total energy
intake, decade of visit, race,
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains
Q1 25·7 (SE 0·2) v.
Q5 24·3 (SE 0·2)
P< 0·0001
Weight (kg) Q1 75·6 (SE 0·7) v.
Q5 71·4 (SE 0·8)
P= 0·0004
Waist
circumference
(cm)
9·74 g/d 2·31g/d Q1 87·4 (SE 0·6) v.
Q5 84·1 (SE 0·6)
P< 0·0001
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Table 6. Continued
Study first author,
year (reference) Study Cohort Participants Cou-ntry Outcome Highest intake Lowest intake Covariates Results P
McKeown 2009(33) Cross-sectional 3 year trial
(vitamin K
and bone
loss)
324 M+F USA BMI (kg/m2) 9·3 g/d 2·4g/d Age, sex, total energy intake,
percentage energy from fat,
physical activity, smoking
status, alcohol intake and
multivitamin use
Q1 27·3 (26·1,
28·6) v. Q4 25·4
(24·2, 26·7)
P= 0·01
Body fat (%) Q1 34·7 (32·8,
36·6) v. Q4 31·5
(29·4, 33·5)
P= 0·004
Trunk fat mass (%) Q1 42·8 (40·2,
45·4) v. Q4 37·8
(35·0, 40·6)
P= 0·001
Van de Vijver
2007(34)
Cross-sectional NLCS 4237 M+F Nether-lands BMI (kg/m2) N/A N/A Age, energy intake, intake of
animal protein, education,
smoking status, number of
cigarettes, intake of fruits
and vegetables
M: b –0·04
(–0·06, –0·02)
P< 0·01
F: b 0·01
(–0·03, 0·05)
P> 0·05
Overweight risk M: OR 0·98 (95%
CI 0·96, 0·99)
P< 0·01
F: OR 1·00 (95%
CI 0·97, 1·02)
P> 0·05
Obesity risk M: OR 0·97 (95%
CI 0·92, 1·02)
P> 0·05
F: OR 1·03 (95%
CI 0·98, 1·07)
P> 0·05
PCS, prospective cohort study; FMC, Finnish Mobile Clinic Health Examination Survey; F, female; M, male; T2DM, type 2 diabetes mellitus; RR, relative risk; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMA-
IR, homoeostatic model assessment of insulin resistance; HR, hazard ratio; ERA, Estrogen Replacement and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort Study; N/
A, not available.
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Table 7. Characteristics of studies within expanded analysis exploring associations of bran intake with outcomes related to CVD
Study first author, year
(reference) Study Cohort Participants Country Outcome Bran Highest intake Lowest intake Covariates Results P
Jensen, 2006(22) Cross-
sectional
HPFS and
NHS II
468 M+470 F USA HbA1c (%) Total* 13·56 g/d 1·42 g/d Age, sex, smoking status,
BMI, physical activity,
hypercholesterolaemia,
alcohol intake, total energy
intake, intake of fruits,
vegetables, germ, sucrose
and fructose
Q1 5·45 (SE 0·04) v.
Q5 5·50 (SE 0·05)
P=0·53
Insulin (pmol/l) Q1 86·8 (SE 4·9) v.
Q5 76·4 (SE 3·5)
P=0·14
C-peptide (ng/ml) Q1 2·11 (SE 0·10) v.
Q5 1·84 (SE 0·06)
P=0·05
Leptin (ng/ml) Q1 8·67 (SE 1·04) v.
Q5 8·5 (SE 1·04)
P=0·88
Total cholesterol
(mmol/l)
Age, sex, smoking status,
BMI, physical activity,
hypercholesterolaemia,
alcohol intake, total energy
intake, intake of fruits,
vegetables, germ,
saturated fat, MUFA and
PUFA
Q1 5·8 (SE 0·09) v.
Q5 5·6 (SE 0·07)
P=0·06
HDL-cholesterol
(mmol/l)
Q1 1·7 (SE 0·03) v.
Q5 1·6 (SE 0·03)
P=0·06
LDL-cholesterol
(mmol/l)
Q1 3·3 (SE 0·08) v.
Q5 3·2 (SE 0·06)
P=0·13
CRP (mg/l) Q1 0·99 (SE 1·09) v.
Q5 0·77 (SE 1·08)
P=0·08
Fibrinogen (g/l) Q1 2·2 (SE 0·03) v.
Q5 2·2 (SE 0·03)
P=0·87
IL-6 (pg/ml) Q1 1·13 (SE 1·05) v.
Q5 1·13 (SE 1·13)
P=0·82
Homocysteine
(µmol/l)
Q1 12·9 (SE 0·5) v.
Q5 11·5 (SE 0·4)
P=0·02
Liu, 1999(23) PCS NHS I 75 521 F USA CHD Added† 1·0 serves/d‡ 0 serves/d BMI, smoking status, alcohol
intake, family history of MI
before 60 year, self-
reported history of
hypertension or
hypercholesterolaemia,
menopausal status,
protein intake, aspirin use,
use of multiple vitamin or
vitamin E supplements,
vigorous activity and total
energy intake
RR 0·63 (95% CI
0·42, 0·95)
P=0·001
Juan, 2017(24) PCS NHS I and
HPFS
71 750
F+42823
M
USA Stroke Total F: 8·50 g/d F: 1·10g/d Age, BMI, smoking status,
alcohol intake, physical
activity, family history of
diabetes mellitus, cancer
and heart disease,
HR 1·00 (95% CI
0·86, 1·16)
P=0·62
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T2DM among healthy participants within the NHS I (relative risk
(RR) 0·75, 95% CI 0·68, 0·83, P< 0·001 and RR 0·72, 95% CI
0·65, 0·80, P< 0·001, respectively) and the NHS II (RR 0·86, 95%
CI 0·72, 1·02, P= 0·03 and RR 0·84, 95% CI 0·71, 1·00, respec-
tively)(19); however, the inverse association with total bran
intake within the NHS II only reached borderline significance
(P= 0·07).
Whole grain intake was associated with a 19% lower risk of
hypertension(20) (RR 0·81, 95% CI 0·75, 0·87, P< 0·0001) and a
16% lower risk of CHD(5) (HR 0·84, 95% CI 0·71, 0·98, P= 0·02)
in the HPFS, when comparing the highest quartile of intake to
lowest. However, after adjusting for cereal fibre intake(20) and
whole grain constituents including dietary fibre(5), both of these
association were attenuated (P= 0·23 and P= 0·06, respec-
tively), suggesting some significance of the cereal fibre com-
ponent towards the whole grain association. Bran intake was
also inversely associated with risk of both hypertension and
CHD (RR 0·85, 95% CI 0·78, 0·92, P= 0·002 and HR 0·72, 95%
CI 0·61, 0·84, P< 0·001, respectively), and the association with
lower risk of CHD remained significant after adjusting for
constituents (P< 0·001).
Whole grain intake compared with bran and cereal fibre
intake. Within the HPFS, whole grain, bran and cereal fibre
intake were associated with better weight management over
time(21). The association was stronger for whole grain intake
than for cereal fibre or bran intake. For every 40 g/d increase in
whole grain intake, 8-year weight gain was 1·1 kg lower
(P< 0·0001), while for every 20 g/d increase in cereal fibre or
bran intake, 8-year weight gain was 0·81 kg (P= 0·0002) and
0·36 kg lower (P= 0·01), respectively, indicating a slightly
stronger association for whole grain intake.
Lower risks of CVD mortality and all-cause mortality were
found for high whole grain, cereal fibre and bran (total and
added) intake in a cohort of 7822 women with existing
T2DM(4). However, after adjustment for lifestyle and dietary
factors, only the associations for total and added bran intake
remained significant for both outcomes. A 64% lower risk of
CVD mortality (RR 0·36, 95% CI 0·24, 0·54, P< 0·001) and a
55% lower risk of all-cause mortality (RR 0·45, 95% CI 0·36,
0·57, P< 0·001) were observed for those consuming the highest
intake of added bran compared with non-consumers.
Whole grain, bran and cereal fibre were significantly inver-
sely related to C-reactive protein (CRP) and TNF receptor 2
levels in a fair quality analysis of women with T2DM within the
NHS I(17), but no association was found with E-selectin or
intercellular adhesion molecule 1 levels. Notably, within this
study no adjustment was made for other dietary factors that may
be correlated with whole grain intake and influence inflam-
mation, such as PUFA intake.
Expanded analysis
Eleven of thirteen articles within the expanded analysis found a
significant inverse association between whole grain intake and
at least one CVD-related outcome analysed(22,23,25–29,31–34),
though six of these found the association no longer significantTa
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after adjustment for cereal fibre intake(23,25–29), indicating cereal
fibre as a key component in the association. All eight articles
that analysed cereal fibre intake separately found a significant
inverse association with at least one CVD-related out-
come(26–29,31–34). One article investigating bran intake found
mixed association(22), while the other two found significant
inverse association(23,24).
Whole grain intake compared with bran intake. One fair
quality analysis(22) considered association of whole grain and
bran intake with lipid profile, markers of glycaemic control and
inflammation. The highest consumers of whole grains (quintile
5; Q5) had 2·9% lower total cholesterol (P= 0·02), 5·3% lower
HDL-cholesterol (P= 0·05) and 2·1% lower LDL-cholesterol
than the lowest consumers (quintile 1; Q1), although the
association with LDL-cholesterol did not reach significance
(P= 0·10). Highest whole grain intake (Q5) was also associated
with 17·4% lower levels of homocysteine as well as lower
concentrations of C-peptide (–13·6%, P= 0·03) and leptin (–
11·0%, P= 0·03). Other markers examined, including HbA1c,
were not associated with whole grain intake. Similar associa-
tions were seen when examining bran intake separately but
were only borderline statistically significant, with the exception
of homocysteine concentrations (–10·9%, P= 0·02). Leptin was
not associated with bran intake (–2·0%, P= 0·88).
Whole grain and bran intake were both associated with lower
incidence of CHD in a good quality prospective cohort study(23)
(RR 0·75, 95% CI 0·59, 0·95, P= 0·01 and RR 0·63, 95% CI 0·42,
0·95, P= 0·001, respectively), with participants consuming one
serving of added bran per d observing a 37% lower risk of CHD
compared with non-consumers. These significant associations
were found after adjustment for several related lifestyle and diet
covariates including smoking status, physical activity and fatty
acid composition of diet, however, the association with whole
grain intake was attenuated after further adjustment for grain
constituents including dietary fibre (P= 0·07). High total bran
intake was associated with 11% lower risk of stroke (HR 0·89,
95% CI 0·79, 1·0, P= 0·004) in a separate good quality pooled
cohort study, whereas whole grain intake showed no
association(24).
Whole grain intake compared with cereal fibre intake.
Whole grain intake was associated with a 21% (95% CI 0·65,
0·96, P= 0·0089) to 35% (95% CI 0·36, 1·18, P= 0·02) lower risk
of T2DM comparing the highest intake to the lowest intake in
three studies (one good quality, two fair quality)(25–27). Impor-
tantly, the two fair quality studies failed to adjust for potentially
important covariates including physical activity(26) and related
dietary factors such as fruit and vegetable intake(27). A fourth
study of fair quality found a 33% lower risk (95% CI 0·48, 0·91,
P= 0·01) of the metabolic syndrome(28). The association com-
pletely disappeared when adjusting for cereal fibre in all four
cases. The three fair quality studies also observed association
for cereal fibre intake separately and found that the highest
intake was associated with a 36% (95% CI 0·53, 0·79,
P= 0·0001) to 61% (95% CI 0·20, 0·77, P= 0·01) lower risk of
T2DM, and a 38% (95% CI 0·45, 0·86, P= 0·002) lower risk of
the metabolic syndrome. Meyer et al.(27) adjusted this result for
whole grain intake, and the lower risk was only slightly reduced
to 34% (95% CI 0·53, 0·83, P= 0·0001).
The association of whole grain and cereal fibre intake with
all-cause mortality and CVD-mortality was explored in a large,
good quality analysis of 367 442 US participants(29). High whole
grain intake was associated with a 17% lower risk of both
outcomes (95% CI 0·81, 0·86, P< 0·0001 and 95% CI 0·78, 0·88,
P< 0·001, respectively). Once adjusted for cereal fibre, the
association with all-cause mortality was attenuated to 6% (95%
CI 0·90, 0·97, P= 0·002), and the association with CVD mortality
completely disappeared (HR 0·95, 95% CI 0·88, 1·03, P= 0·188).
High cereal fibre intake, analysed separately within the same
study, was associated with very similar lower risk of all-cause
and CVD mortality. In a smaller, fair quality study(30), whole
grain consumers tended to have lower risk of all-cause mortality
(HR 0·83, 95% CI 0·73, 0·94, P< 0·05) compared with refined
grain consumers.
The association of whole grain and cereal fibre intake to
progression of coronary atherosclerosis among 229 women
were analysed within a fair quality study(31). Women consum-
ing above the median intake of whole grains (>6 serves/week)
and cereal fibre intake (>3 g/4184 kJ (1000 kcal)) had a sig-
nificantly smaller change in minimum coronary artery diameter
over the 3-year period compared with those consuming under
the median (–0·06 v. –0·10mm, P= 0·04 and –0·04 v. –0·09mm,
P= 0·03, respectively).
Two fair quality cross-sectional articles examined whole grain
and cereal fibre intake in relation to glycaemic control. In the
Framingham Offspring Study, mean homoeostasis model
assessment-estimated insulin resistance (HOMA-IR) was bor-
derline significantly lower in the highest quintile of whole grain
Table 8. Classification of study design as per National Health and Med-
ical Research Council (NHMRC) level of evidence guidelines and classi-
fication of quality as per National Institutes of Health (NIH) quality
assessment tool for observational cohort and cross-sectional studies
Reference
NHMRC level
of evidence
NIH quality assessment
tool rating
Initial analysis
He (2010)(4) II Good
Jensen (2004)(5) II Good
Qi (2006)(17) IV Fair
Wu (2015)(18) II Good
de Munter (2007)(19) II Good
Flint (2009)(20) III-2 Good
Koh Banerjee (2004)(21) II Good
Expanded analysis
Jensen (2006)(22) IV Fair
Liu (1999)(23) II Good
Juan (2017)(24) II Good
Fung (2002)(25) II Good
Montonen (2003)(26) II Fair
Meyer (2000)(27) II Fair
McKeown (2004)(28) IV Fair
Huang (2015)(29) II Good
Jacobs (2000)(30) II Fair
Erkkila (2005)(31) III-2 Fair
Newby (2007)(32) IV Fair
McKeown (2009)(33) IV Fair
Van de Vijver (2009)(34) IV Fair
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intake (quintile 5; Q5) compared with the lowest (quintile 1;
Q1) (Q1 6·8 v. Q5 6·6, P= 0·05); however, this association
disappeared once adjusted for cereal fibre(28). In contrast, the
association between high cereal fibre intake and lower mean
HOMA-IR remained after adjusting for whole grain intake (Q1
6·9 v. Q5 6·5, P= 0·003). Within the Baltimore Longitudinal
Study of Aging, higher whole grain and cereal fibre intake were
similarly associated with lower postprandial glucose (quintile 1
(Q1) 8·24mmol/l v. quintile 5 (Q5) 7·23mmol/l, P= 0·006 and
Q1 8·05mmol/l v. Q5 6·48mmol/l, P= 0·02, respectively);
however, no association with fasting glucose, fasting insulin or
postprandial insulin were found(32).
Within the same study, the highest consumers of whole grain
and cereal fibre had significantly lower total cholesterol than the
lowest consumers (Q1 5·79mmol/l v. Q5 5·49mmol/l, P= 0·02
and Q1 5·73mmol/l v. Q5 5·44mmol/l, P= 0·005, respectively).
The highest consumers of both intake also had lower LDL-
cholesterol than the lowest consumers, though this was bor-
derline significant for cereal fibre intake (Q1 3·13mmol/l v. Q5
2·9mmol/l, P= 0·07), and somewhat negatively, the highest
consumers of whole grain intake had lower HDL-cholesterol,
though not significantly (Q1 1·27 mmol/l v. Q5 1·22mmol/l,
P= 0·07).
Participants consuming the highest intake of whole grain and
cereal fibre had significantly lower anthropometric body mea-
surements compared with those consuming the lowest intake in
three cross-sectional analyses(32–34), though notably two of the
three studies did not perform an adjustment for physical activity
within their multivariate models(32,34). Within the Netherlands
Cohort Study, it was estimated that every 1 g/d higher intake of
whole grain was associated with a 0·03 and 0·04 kg/m2 lower
BMI in men and women, respectively (P< 0·01 for both)(34).
This meant that a decrease of 1 kg/m2 BMI corresponded to a 33
and 25 g increase in whole grain intake. Every 1 g of cereal fibre
intake was similarly associated with a 0·04 kg/m2 lower BMI in
men (P< 0·01), but no association was found for women.
Within the same cohort, a high intake of whole grain was
associated with a slightly lower risk of being overweight and
obese in both men (OR 0·98, 95% CI 0·96, 0·99, P< 0·01 and OR
0·90, 95% CI 0·84, 0·98, P< 0·05, respectively) and women (OR
0·98, 95% CI 0·96, 0·99, P< 0·01 and OR 0·96, 95% CI 0·93, 0·99,
P< 0·05, respectively), while a high intake of cereal fibre was
only associated with a lower risk of being overweight in men
(OR 0·98, 95% CI 0·96, 0·99, P<0·01). van de Vijver et al. also
conducted a prospective analysis of a smaller cohort of 1257
participants, with follow-up ranging 1–5 years, but no associa-
tion was found between baseline intake and anthropometric
measures.
Discussion
Within the review, the association between whole grains, bran
and cereal fibre and lower risk of CVD-related outcomes were
evident. In the expanded analysis, cereal fibre and whole grain
(including added bran) intake were similarly associated with
lower risk of CVD mortality, and the fibre component tended to
explain the association(29), whereas fibre-rich bran was strongly
associated with lower risk of stroke incidence(24). The inverse
association between the risk of CVD-related outcomes and
cereal fibre intake may be due to favourable effects on factors
likely to influence the development of the disease such as
serum lipids(35), glucose and insulin metabolism(36), blood
pressure(37) and inflammation(38). These factors may also play a
role in slowing progression of CVD, as higher intake of cereal
fibre and whole grain products were both associated with less
progression of coronary atherosclerosis in postmenopausal
women with established CHD(31). The differences in progres-
sion (0·04mm less progression in high whole grain consumers;
0·05mm less progression in high cereal fibre consumers) were
somewhat comparable with treatment effects reported in statin
trials (0·06–0·08mm)(39).
Interestingly when studies assessed added bran intake (bran
added to food during processing), some of the strongest inverse
association with CVD-related outcomes were found. As added
bran, as opposed to total bran, does not include bran intake
consumed as part of whole grain foods, there is less chance of it
being simply a surrogate marker for whole grain intake, pro-
viding a more precise insight into the benefits of bran alone. In
the study by He et al.(4) of women with T2DM, only added bran
was significantly associated with lower CVD-related and all-
cause mortality after adjustment for related lifestyle and dietary
factors. While this study was underpowered to detect modest
associations; and therefore, the non-significant associations
found for whole grain and cereal fibre may be due to limited
power, the same strong inverse association with CVD mortality
and all-cause-mortality was found for added bran intake in
healthy participants(18). Furthermore, added bran had the
strongest inverse association with CHD(5,23). One possible
explanation for the consistently strong inverse associations
found for added bran is that within these populations, bran is
sourced mainly from only two sources, wheat bran and oat
bran(5). Oat bran is one of the highest sources of the soluble
fibre β-glucan, which is consistently associated with reduced
serum total LDL-cholesterol in clinical trials(40,41).
However, the direct association within the cross-sectional
studies of whole grain, cereal fibre and total bran intake to
serum cholesterol levels were less consistent(22,32). Again,
association may have been stronger if specifically analysing
intake of high-soluble fibre grains. Cross-sectional studies are
inherently unable to capture the impact of long-term trends in
intake, and sample sizes were relatively small within both
studies. For example, while a 4·7% lower LDL-cholesterol level,
as found in one study comparing highest consumers of cereal
fibre with lowest consumers(32), may appear clinically relevant
to reduced CVD risk(42), it did not quite reach statistical sig-
nificance (P= 0·07).
It is thought that whole grains may contribute to weight loss
through the effect of fibre on satiation and satiety(43), leading to
lower energy intake. In addition, the secretion of particular gut
hormones such as cholecystokinin may contribute to satiety or
alter glucose homoeostasis(44), and soluble fibre may improve
insulin sensitivity by slowing the absorption of macronutrients,
indirectly affecting body weight(43). While the inverse associa-
tion within the HPFS between whole grain, added bran and
cereal fibre intake and weight gain over an 8-year period were
20 E. M. Barrett et al.
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statistically significant, the weight change differences between
the highest and lowest intake were modest(21). Considering the
findings for whole grains and fibre intake effect on weight
regulation in clinical trials tend to be inconsistent(45–47), further
research investigating this relationship is needed.
Within this review, whole grain intake tended to be asso-
ciated with lower incidence of T2DM and the metabolic syn-
drome, but this association consistently disappeared after
adjustments for cereal fibre intake. The one study that did not
perform adjustments for cereal fibre intake found similar risk
reductions between whole grain and bran(19). High-soluble
fibre foods have been found to reduce post-prandial glucose
and insulin response(48) and high-fibre diets may improve
insulin sensitivity and lower insulin secretion(49). Interestingly,
two studies within the review found that insoluble fibre but not
soluble fibre was associated with lower risk of T2DM(26,27).
Insoluble fibre may also slow the absorption of foods(50), but it
is also suggested that a quicker transit time, achieved with high-
insoluble fibre intake, allows less time for carbohydrates to be
absorbed in the upper jejunum, thus relieving insulin demand(51).
Both whole grain and cereal fibre intake were associated with
significantly lower HOMA-IR, a measure of insulin resistance, in
the Framingham cohort even after adjustment for relevant life-
style and dietary factors. However, the whole grain association
disappeared after adjustment for cereal fibre(28).
In addition to the fibre content, micronutrients within whole
grains such as Mg may also play a role in insulin sensitivity and
reduced risk of T2DM. In a small study of elderly participants,
4·5 g of Mg daily for 4 weeks improved glucose and insulin
responses(52). Within our review, the importance of Mg intake
was inconclusive. Some studies found that Mg intake could not
explain the whole grain association(19,26), while another found
Mg was independently associated with reduced risk of T2DM,
even after adjustment for cereal fibre(27). Importantly, this study
did not adjust for any other related dietary factors that may
confound these associations. Overall, the findings suggest that
the fibre component of whole grains and bran may play the
major role in the inverse association with T2DM. Other nutrients
such as Mg may also contribute.
CRP was the only inflammatory marker regularly assessed.
Elevated CRP concentrations, a marker of inflammation, have
been found to independently predict CVD in the general
population(53) and people with T2DM(54), and the American
Heart Association has concluded that the risk of CVD is lower
when the CRP level is below 1mg/l(55). Here, high whole grain,
bran and cereal fibre intake were significantly associated with
lower CRP concentrations in the same cohort of women with
T2DM(17). Within a healthy population, high whole grain and
bran intake tended to be associated with lower CRP con-
centrations; however, after adjustment for dietary and lifestyle
factors, the association completely disappeared for whole grain
and became non-significant for bran(22). Hyperglycaemia may,
in part, influence production of pro-inflammatory cyto-
kines(56,57), so whole grain and cereal fibre intake may assist in
inhibiting inflammation through an effect on blood glucose
control.
The findings of this review suggest that fibre may play a
significant role in the cardio-protective association of whole
grains. Whole grain, bran and cereal fibre intake were asso-
ciated with similarly lowered risks of most outcomes assessed,
and when tested, cereal fibre often accounted considerably for
whole grain associations, particularly for T2DM. When bran was
separated from whole grains as in the initial analysis, intake of
bran, particularly added bran, had equal or stronger inverse
association with various CVD-related outcomes to that of whole
grains. As bran contains the majority of cereal fibre within
grains, this may further support the notion that fibre contributes
considerably to the protective associations of grains. Of course,
it is important to note that bran cannot be interpreted simply as
a direct measure of cereal fibre, due to the abundance of
minerals, phytochemicals and phyto-oestrogens contained
within the aleurone layer(58). In the HPFS cohort, adjusting for
fibre and micronutrient constituents attenuated the inverse
association between whole grains and CHD but did not have an
appreciable effect on the strong inverse association for added
bran(5). Further, Jacobs et al.(30) found that consumers of fibre
from whole grain sources (which included bran) compared with
fibre from refined grain sources tended to have lower risk of all-
cause mortality but not specifically CVD mortality. We cannot
disregard the possibility that these bioactive compounds within
the bran aleurone layer, botanically linked to fibre, may con-
tribute to the inverse associations found(30).
Another important consideration in examining associations
between whole grains and CVD-related outcomes is the diet
and lifestyle of whole grain consumers, beyond whole grain
consumption. Whole grain intake may be associated with an
overall healthier lifestyle and better diet quality(59), and some of
these associated factors such as higher physical activity levels,
lower incidence of smoking and higher fruit and vegetable
intake may confound or contribute to any associations
attributed to whole grain intake. Within the initial analysis, all
seven of the good quality articles included careful adjustment
for multiple lifestyle and dietary factors in their multivariate
models. However, the fair quality article(17) observing associa-
tions with markers of inflammation included lifestyle factors
within the multivariate model, without inclusion of potentially
relevant dietary factors such as polyunsaturated fat intake(60).
Similarly, several of the articles included within the expanded
analysis failed to adjust for factors such as physical activity
status(26,31,32,34), alcohol intake(26) and other dietary factors(27).
In some cases, articles reporting on the same study cohorts
adjusted for considerably different factors within their
multivariate models. As causation cannot be determined from
observational studies, it is crucial that careful adjustment is
made for all potentially confounding factors. The inconsistency
among several articles within the review, particularly within the
expanded analysis, may limit the quality of the overall evidence.
Many of the articles within this review also went on to adjust
for constituents within the whole grain, including cereal fibre. It
was interesting that associations found within the initial analysis
were less prone to attenuation after adjustment for cereal fibre
than in the expanded analysis. Using an accepted definition of
whole grain (including all fractions in natural proportions), and
methodical calculation of whole grain, bran and cereal fibre
intake, results are less likely to be confounded by imprecise
categorisation. We can therefore be more confident that the
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abundance of nutrients expected to be found within whole
grains and the separate bran component were accurately cap-
tured in estimated intake. Beyond the incorrect inclusion of
added bran, it is possible that the presence of non-whole grain
(and therefore potentially nutrient poor) grain intake incorrectly
captured as whole grain intake within the expanded analysis
diluted the overall quality of intake and therefore blunted the
contribution of any whole grain nutrients beyond cereal fibre.
The noticeable difference in results between initial and
expanded analysis suggests that while it is evident that cereal
fibre is an important component of whole grain and bran, we
cannot disregard contribution from nutrients beyond this.
The inconsistency in definitions and categorisation systems
used, and therefore limited amount of evidence based on the
correct definition of whole grains, is a considerable limitation of
this review. Only three major study cohorts (the NHS I and II
and the HPFS) were analysed using the correct definition of
whole grains. In addition, while the wide variety of CVD-related
outcomes assessed shed light on the various ways whole grain
intake may be protective, we were limited in our ability to draw
sound conclusions about any one risk factor or outcome, as
most outcomes were assessed in few studies, in diverse popu-
lations, or using different definitions of whole grain, making a
more in-depth study of results by way of a meta-analysis not
possible.
Conclusion
Intake of whole grain, cereal fibre and bran (total and added)
appeared to be similarly associated with lower risk of various
CVD-related risk factors and outcomes within this review,
suggesting that the fibre component of whole grains, located
primarily within the bran fraction, may play an important role in
the cardio-protective associations observed with whole grain
intake. Notably, however, when the accepted definition and
precise categorisation of whole grain and bran intake were
used, association found were stronger and less prone to
attenuation after adjustment for cereal fibre, potentially indi-
cating a role of whole grain nutrients beyond fibre.
The findings from this review are interesting in consideration
of the promotion of grain foods in public health initiatives and
dietetic practice. Potentially, an overly restricted focus on whole
grain cereal foods may deter consumption of high-fibre non-
whole grain foods such as bran-based cereals. The similar lower
risks observed for added bran separate to whole grain across
both analyses raise the question of whether current initiatives
and health policies should include mention of whole grain and/
or bran foods. Indeed, this question may also be valuable for
the food industry, whereby the reformulation of cereal products
containing extrinsically sourced cereal fibre or fine bran may
overcome sensory barriers to whole grain foods – while still
providing cardio-protective benefits. Future adequately pow-
ered studies, including intervention studies comparing the
effects of whole grain intake with fibre-matched bran or added-
cereal fibre intake on CVD-related risk factors and outcomes,
are needed to establish the mechanisms behind the protective
effects of whole grains and their components as well as the
dose–response relationships, where there is currently paucity of
data and lack of agreement. These studies are needed before
findings can be translated into practical application. Most
importantly, there is a crucial need for future research to utilise
a consistent, methodical and quantified approach when calcu-
lating whole grain intake to ensure future evidence in this area
is consistent and accurate and reflects the current definition of
whole grain.
Acknowledgements
The authors thank Professor Chris Seal (Newcastle University)
for guidance and support in the design of the review.
This research has been conducted with the support of the
Australian Government Research Training Program Scholarship.
No other funding has been provided.
E. M. B. and E. J. B. designed the research; E. M. B. and E. J. B.
conducted research; E. M. B. and M. J. B. analysed data; E. M. B.
and E. J. B. wrote the paper; S. R. reviewed synthesis of data
results and reviewed manuscript; E. M. B. had primary respon-
sibility for final content.
The authors declare that there are no conflicts of interest.
Supplementary material
For supplementary material/s referred to in this article, please
visit https://doi.org/10.1017/S000711451900031X
References
1. World Health Organization (2017) Cardiovascular diseases
fact sheet. http://www.who.int/mediacentre/factsheets/fs317/
en/ (accessed February 2018).
2. Pearson TA (2002) AHA Guidelines for Primary Prevention of
Cardiovascular Disease and Stroke: 2002 Update: Consensus
Panel Guide to Comprehensive Risk Reduction for Adult
Patients Without Coronary or Other Atherosclerotic Vascular
Diseases. Circulation 106, 388–391.
3. Yusuf S, Hawken S, Ounpuu S, et al. (2004) Effect of poten-
tially modifiable risk factors associated with myocardial
infarction in 52 countries (the INTERHEART study): case–
control study. Lancet 364, 937–952.
4. He M, van Dam RM, Rimm E, et al. (2010) Whole-grain, cereal
fiber, bran, and germ intake and the risks of all-cause and
cardiovascular disease-specific mortality among women with
type 2 diabetes mellitus. Circulation 121, 2162–2168.
5. Jensen MK, Koh-Banerjee MF, Hu FB, et al. (2004) Intakes of
whole grains, bran, and germ and the risk of coronary heart
disease in men. Am J Clin Nutr 80, 1492–1499.
6. Theuwissen E & Mensink RP (2008) Water-soluble dietary fibers
and cardiovascular disease. Physiol Behav 94, 285–292.
7. Fardet A (2010) New hypotheses for the health-protective
mechanisms of whole-grain cereals: what is beyond fibre?
Nutr Res Rev 23, 65–134.
8. Cassidy A & Hooper L (2006) Phytoestrogens and cardiovas-
cular disease. J Br Menopause Soc 12, 49–56.
9. Aune D, Keum N, Giovannucci E, et al. (2016) Whole grain
consumption and risk of cardiovascular disease, cancer, and all
cause and cause specific mortality: systematic review and dose–
response meta-analysis of prospective studies. BMJ 353, i2716.
10. Ye EQ, Chacko SA, Chou EL, et al. (2012) Greater whole-grain
intake is associated with lower risk of type 2 diabetes, cardio-
vascular disease, and weight gain. J Nutr 142, 1304–1313.
22 E. M. Barrett et al.
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . U
niversity of W
ollongong , on 25 M
ar 2019 at 22:55:33 , subject to the Cam
bridge Core term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S000711451900031X
11. Jacobs DR Jr, Meyer KA, Kushi LH, et al. (1998) Whole-grain
intake may reduce the risk of ischemic heart disease death in
postmenopausal women: the Iowa Women’s Health Study.
Am J Clin Nutr 68, 248–257.
12. Ross AB, van der Kamp JW, King R, et al. (2017) Perspective: a
definition for whole-grain food products-recommendations
from the healthgrain forum. Adv Nutr 8, 525–531.
13. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA
statement for reporting systematic reviews and meta-analyses
of studies that evaluate healthcare interventions: explanation
and elaboration. PLoS Med 6, e1000100.
14. American Association of Cereal Chemists International (2017))
Standard definitions and resources: whole grain. http://www.
aaccnet.org/initiatives/definitions/Pages/WholeGrain.aspx
(accessed September 2017).
15. National Health and Medical Research Council (2000) How to
use the evidence: assessment and application of scientific
evidence. https://www.nhmrc.gov.au/guidelines-publications/
cp69 (accessed September 2017).
16. National Institute of Health (2014) Quality assessment tool for
observational cohort and cross-sectional studies. https://www.
nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-
risk-reduction/tools/cohort (accessed September 2017).
17. Qi L, van Dam RM, Liu S, et al. (2006) Whole-grain, bran, and
cereal fiber intakes and markers of systemic inflammation in
diabetic women. Diabetes Care 29, 207–211.
18. Wu H, Flint AJ, Qi Q, et al. (2015) Association between dietary
whole grain intake and risk of mortality: two large prospective
studies in US men and women. JAMA Intern Med 175,
373–384.
19. de Munter JSL, Hu FB, Spiegelman D, et al. (2007) Whole
grain, bran, and germ intake and risk of type 2 diabetes: a
prospective cohort study and systematic review. PloS Med 4,
e261.
20. Flint AJ, Hu FB, Glynn RJ, et al. (2009) Whole grains and
incident hypertension in men. Am J Clin Nutr 90, 493–498.
21. Koh-Banerjee MF, Franz M, Sampson L, et al. (2004) Changes
in whole-grain, bran, and cereal fiber consumption in
relation to 8-y weight gain among men. Am J Clin Nutr 80,
1237–1245.
22. Jensen MK, Koh-Banerjee MF, Sampson L, et al. (2006) Whole
grains, bran, and germ in relation to homocysteine and mar-
kers of glycemic control, lipids, and inflammation. Am J Clin
Nutr 83, 275–283.
23. Liu S, Stampfer MJ, Hu FB, et al. (1999) Whole-grain con-
sumption and risk of coronary heart disease: results from the
Nurses’ Health Study. Am J Clin Nutr 70, 412–308.
24. Juan J, Liu G, Willett WC, et al. (2017) Whole grain
consumption and risk of ischemic stroke: results from 2
prospective cohort studies. Stroke 48, 3203–3209.
25. Fung TT, Hu FB, Pereira MA, et al. (2002) Whole-grain intake
and the risk of type 2 diabetes: a prospective study in men.
Am J Clin Nutr 76, 535–540.
26. Montonen J, Knekt P, Jarvinen R, et al. (2003) Whole-grain
and fiber intake and the incidence of type 2 diabetes. Am J
Clin Nutr 77, 622–629.
27. Meyer KA, Kushi LH, Jacobs DR, et al. (2000) Carbohydrates,
dietary fiber, and incident type 2 diabetes in older women. Am
J Clin Nutr 71, 921–930.
28. McKeown NM, Meigs JB, Liu S, et al. (2004) Carbohydrate
nutrition, insulin resistance, and the prevalence of the meta-
bolic syndrome in the Framingham Offspring Cohort. Diabetes
Care 27, 538–546.
29. Huang T, Xu M, Lee A, et al. (2015) Consumption of whole
grains and cereal fiber and total and cause-specific mortality:
prospective analysis of 367,442 individuals. BMC Med 13, 59.
30. Jacobs DR, Pereira MA, Meyer KA, et al. (2000) Fiber from
whole grains, but not refined grains, is inversely associated
with all-cause mortality in older women: the Iowa Women’s
Health Study. J Am Coll Nutr 19, Suppl. 3, 326S–330S.
31. Erkkila AT, Herrington DM, Mozaffarian D, et al. (2005) Cereal
fiber and whole-grain intake are associated with reduced
progression of coronary-artery atherosclerosis in post-
menopausal women with coronary artery disease. Am Heart J
150, 94–101.
32. Newby PK, Maras J, Bakun P, et al. (2007) Intake of whole
grains, refined grains, and cereal fiber measured with 7-d diet
records and associations with risk factors for chronic disease.
Am J Clin Nutr 86, 1745–1753.
33. McKeown NM, Yoshida M, Shea MK, et al. (2009) Whole-grain
intake and cereal fiber are associated with lower abdominal
adiposity in older adults. J Nutr 139, 1950–1955.
34. van de Vijver LP, van den Bosch LM, van den Brandt PA, et al.
(2009) Whole-grain consumption, dietary fibre intake and
body mass index in the Netherlands cohort study. Eur J Clin
Nutr 63, 31–38.
35. Jenkins DJ, Kendall CW, Axelsen M, et al. (2000) Viscous and
non-viscous fibres, non-absorbable and low glycaemic index
carbohydrates, blood lipids and coronary heart disease. Curr
Opin Lipidol 11, 49–56.
36. Juntunen KS, Laaksonen DE, Poutanen KS, et al. (2003) High-
fiber rye bread and insulin secretion and sensitivity in healthy
postmenopausal women. Am J Clin Nutr 77, 385–391.
37. Appel LJ, Moore TJ, Obarzanek E, et al. (1997) A clinical trial
of the effects of dietary patterns on blood pressure. N Engl J
Med 336, 1117–1124.
38. King DE, Egan BM & Geesey ME (2003) Relation of dietary fat
and fiber to elevation of C-reactive protein. Am J Cardiol 92,
1335–1339.
39. Ballantyne CM (1998) Clinical trial endpoints: angiograms,
events, and plaque instability. Am J Cardiol 82, Suppl. 1,
5M–11M.
40. Anderson JW, Gilinsky NH, Deakins DA, et al. (1991) Lipid
responses of hypercholesterolemic men to oat-bran and
wheat-bran intake. Am J Clin Nutr 54, 678–683.
41. Davy BM, Davy KP, Ho RC, et al. (2002) High-fiber oat cereal
compared with wheat cereal consumption favorably alters
LDL-cholesterol subclass and particle numbers in middle-aged
and older men. Am J Clin Nutr 76, 351–358.
42. National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) (2002) Third
Report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III)
final report. Circulation 106, 3143–3421.
43. Koh-Banerjee P & Rimm EB (2003) Whole grain consumption
and weight gain: a review of the epidemiological evidence,
potential mechanisms and opportunities for future research.
Proc Nutr Soc 62, 25–29.
44. Pereira MA & Ludwig DS (2001) Dietary fiber and body-
weight regulation. Observations and mechanisms. Pediatr
Clin North Am 48, 969–980.
45. Brownlee IA, Moore C, Chatfield M, et al. (2010) Markers of
cardiovascular risk are not changed by increased whole-grain
intake: the WHOLEheart study, a randomised, controlled
dietary intervention. Br J Nutr 104, Suppl. 1, 125S–134S.
46. Rave K, Roggen K, Dellweg S, et al. (2007) Improvement of
insulin resistance after diet with a whole-grain based dietary
product: results of a randomized, controlled cross-over study
in obese subjects with elevated fasting blood glucose. Br J
Nutr 98, 929–936.
Whole grains and CVD 23
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . U
niversity of W
ollongong , on 25 M
ar 2019 at 22:55:33 , subject to the Cam
bridge Core term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S000711451900031X
47. Melanson KJ, Angelopoulos TJ, Nguyen VT, et al. (2006)
Consumption of whole-grain cereals during weight loss effects
on dietary quality, dietary fiber, magnesium, vitamin B-6, and
obesity. J Am Diet Assoc 106, 1380–1388.
48. Jenkins D, Wolever T, Leeds AR, et al. (1978) Dietary fibres,
fibre analogues, and glucose tolerance: importance of visc-
osity. Br Med J 1, 1392–1394.
49. Weickert MO, Mohlig M, Schöfl C, et al. (2006) Cereal fiber
improves whole-body insulin sensitivity in overweight and
obese women. Diabetes Care 29, 775–780.
50. Anderson JW (1986) Fiber and health: an overview. Am J
Gastroenterol 81, 892–897.
51. Cummings JH & Englyst HN (1987) Fermentation in the
human large intestine and the available substrates. Am J Clin
Nutr 45, 1243–1255.
52. Paolisso G, Sgambato S, Gambardella A, et al. (1992) Daily
magnesium supplements improve glucose handling in elderly
subjects. Am J Clin Nutr 55, 1161–1167.
53. Ridker PM, Buring JE, Cook NR, et al. (2003) C-reactive pro-
tein, the metabolic syndrome, and risk of incident cardiovas-
cular events: an 8-year follow-up of 14,719 initially healthy
American women. Circulation 107, 391–397.
54. Schulze MB, Rimm EB, Li T, et al. (2004) C-reactive protein
and incident cardiovascular events among men with diabetes.
Diabetes Care 27, 889–894.
55. Pearson TA, Mensah GA, Alexander RW, et al. (2003) Markers
of inflammation and cardiovascular disease: application to
clinical and public health practice: a statement for healthcare
professionals from the Centers for Disease Control and Pre-
vention and the American Heart Association. Circulation 107,
499–511.
56. Gonzalez F, Minium J, Rote NS, et al. (2005) Hyperglycemia
alters TNF-alpha release from mononuclear cells in women
with polycystic ovary syndrome. J Clin Endocrinol Metab 90,
5336–5342.
57. Devaraj S, Venugopal SK, Singh U, et al. (2005) Hyperglyce-
mia induces monocytic release of interleukin-6 via induction
of protein kinase c-alpha and -beta. Diabetes 54, 85–91.
58. Lillioja S, Neal AL, Tapsell L, et al. (2013) Whole grains, type
2 diabetes, coronary heart disease, and hypertension: links to
the aleurone preferred over indigestible fiber. Biofactors 39,
242–258.
59. Kyrø C, Skeie G, Dragsted L, et al. (2011) Intake of whole
grains in Scandinavia is associated with healthy lifestyle,
socio-economic and dietary factors. Public Health Nutr 14,
1787–1795.
60. Kris-Etherton PM, Harris WS & Appel LJ (2003) Omega-3 fatty
acids and cardiovascular disease: new recommendations from
the American Heart Association. Arterioscler Thromb Vasc
Biol 23, 151–152.
24 E. M. Barrett et al.
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . U
niversity of W
ollongong , on 25 M
ar 2019 at 22:55:33 , subject to the Cam
bridge Core term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S000711451900031X
